Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2020

1.

Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

Transplantation. 2009 Jan 27;87(2):198-206. doi: 10.1097/TP.0b013e3181933261.

PMID:
19155973
2.

Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.

Tian L, Gao J, Hao J, Zhang Y, Yi H, O'Brien TD, Sorenson R, Luo J, Guo Z.

Endocrinology. 2010 Jul;151(7):3049-60. doi: 10.1210/en.2010-0068. Epub 2010 May 5.

PMID:
20444936
3.
4.

Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.

Qin HY, Sadelain MW, Hitchon C, Lauzon J, Singh B.

J Immunol. 1993 Mar 1;150(5):2072-80.

PMID:
8436836
5.

Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice.

Luo X, Yang H, Kim IS, Saint-Hilaire F, Thomas DA, De BP, Ozkaynak E, Muthukumar T, Hancock WW, Crystal RG, Suthanthiran M.

Transplantation. 2005 May 15;79(9):1091-6.

PMID:
15880049
6.

Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.

Huszarik K, Wright B, Keller C, Nikoopour E, Krougly O, Lee-Chan E, Qin HY, Cameron MJ, Gurr WK, Hill DJ, Sherwin RS, Kelvin DJ, Singh B.

J Immunol. 2010 Nov 1;185(9):5120-9. doi: 10.4049/jimmunol.1001596. Epub 2010 Sep 27.

7.

Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development.

Mori Y, Kodaka T, Kato T, Kanagawa EM, Kanagawa O.

Int Immunol. 2009 Nov;21(11):1291-9. doi: 10.1093/intimm/dxp097. Epub 2009 Sep 24.

PMID:
19778991
8.

The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.

Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R.

Diabetes. 2007 May;56(5):1395-402. Epub 2007 Feb 22.

9.

Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.

You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L.

Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6335-40. Epub 2007 Mar 26.

10.

Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.

Gregori S, Giarratana N, Smiroldo S, Adorini L.

J Immunol. 2003 Oct 15;171(8):4040-7.

11.
12.

CD3 antibody treatment stimulates the functional capability of regulatory T cells.

Chatenoud L.

Novartis Found Symp. 2003;252:279-86; discussion 286-90. Review.

PMID:
14609225
13.

Prevention of spontaneous immune-mediated diabetes development in the LEW.1AR1-iddm rat by selective CD8+ T cell transfer is associated with a cytokine shift in the pancreas-draining lymph nodes.

Arndt T, Wedekind D, Weiss H, Tiedge M, Lenzen S, Hedrich HJ, Jörns A.

Diabetologia. 2009 Jul;52(7):1381-90. doi: 10.1007/s00125-009-1348-1. Epub 2009 Apr 15.

PMID:
19367386
14.

Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.

Madec AM, Mallone R, Afonso G, Abou Mrad E, Mesnier A, Eljaafari A, Thivolet C.

Diabetologia. 2009 Jul;52(7):1391-9. doi: 10.1007/s00125-009-1374-z. Epub 2009 May 7.

PMID:
19421731
15.

Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.

Bank U, Tadje J, Täger M, Wolke C, Bukowska A, Ittenson A, Reinhold D, Helmuth M, Ansorge S, Shakespeare A, Vieth M, Malfertheiner P, Naumann M, Lendeckel U.

Int J Mol Med. 2007 Oct;20(4):483-92.

PMID:
17786278
16.

Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes.

Nikoopour E, Schwartz JA, Huszarik K, Sandrock C, Krougly O, Lee-Chan E, Singh B.

J Immunol. 2010 May 1;184(9):4779-88. doi: 10.4049/jimmunol.0902822. Epub 2010 Apr 2.

17.

APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development.

Manirarora JN, Kosiewicz MM, Parnell SA, Alard P.

PLoS One. 2008;3(11):e3739. doi: 10.1371/journal.pone.0003739. Epub 2008 Nov 17.

18.

Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.

Li A, Ojogho O, Franco E, Baron P, Iwaki Y, Escher A.

Vaccine. 2006 Jun 5;24(23):5036-46. Epub 2006 Mar 31. Erratum in: Vaccine. 2007 Jan 4;25(2):399.

PMID:
16621191
19.

Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4.

Ogawa N, List JF, Habener JF, Maki T.

Diabetes. 2004 Jul;53(7):1700-5.

20.

Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.

Ploix C, Bergerot I, Durand A, Czerkinsky C, Holmgren J, Thivolet C.

Diabetes. 1999 Nov;48(11):2150-6.

PMID:
10535448

Supplemental Content

Support Center